Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
作者信息
Tarawneh Omar, Tarawneh Husam
机构信息
Advocate Aurora Health, Milwaukee, Wisconsin, USA.
出版信息
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
Abstract
摘要
相似文献
1
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
2
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
3
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.疫苗诱导的免疫性血栓性血小板减少症：我们已知和未知的。
Blood. 2021 Jul 29;138(4):293-298. doi: 10.1182/blood.2021012152. Epub 2021 Jun 1.
4
Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.新型冠状病毒2型疫苗接种后免疫性血小板减少性紫癜
Br J Haematol. 2021 Aug;194(3):547-549. doi: 10.1111/bjh.17508. Epub 2021 May 2.
5
Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.慢性免疫性血小板减少症患者及一名健康个体接种新型冠状病毒2疫苗后发生急性免疫性血小板减少症
Int J Hematol. 2022 Feb;115(2):293-295. doi: 10.1007/s12185-021-03235-2. Epub 2021 Oct 30.
6
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.免疫性血小板减少症患者接种抗SARS-CoV-2疫苗的安全性
Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
7
AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female.一名年轻女性出现与AZD1222疫苗相关的凝血障碍和血小板减少症，无血栓形成。
Br J Haematol. 2021 Aug;194(3):553-556. doi: 10.1111/bjh.17530. Epub 2021 May 25.
8
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia.慢性或持续性免疫性血小板减少症患者接种新冠疫苗后的血小板变化趋势
Am J Hematol. 2021 Dec 1;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19.
9
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).接种新型冠状病毒疫苗（ChAdOx1 nCoV-19）后发生免疫性血小板减少性紫癜
Blood. 2021 Sep 16;138(11):996-999. doi: 10.1182/blood.2021012790.
10
Relapse of immune thrombocytopenia after COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后免疫性血小板减少症复发
Eur J Haematol. 2022 Jan;108(1):84-85. doi: 10.1111/ejh.13713. Epub 2021 Oct 17.
引用本文的文献
1
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种和感染后实体器官移植受者的白细胞计数
Vaccines (Basel). 2025 Jan 22;13(2):103. doi: 10.3390/vaccines13020103.
2
Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine.第二剂辉瑞新冠疫苗接种后出现免疫性血小板减少性紫癜
BMJ Case Rep. 2022 Sep 2;15(9):e249477. doi: 10.1136/bcr-2022-249477.
3
Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.两例与腺病毒载体疫苗ChAdOx1-S（阿斯利康）相关的免疫性血小板减少症（ITP）及血小板生成素受体激动剂（TPO-RA）治疗后的良好反应
Hematol Rep. 2024 Sep 27;16(4):585-592. doi: 10.3390/hematolrep16040057.
4
Diagnostic features of autoimmune hepatitis in SARS‑CoV‑2‑vaccinated vs. unvaccinated individuals.接种与未接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗个体自身免疫性肝炎的诊断特征
Exp Ther Med. 2024 Jun 26;28(3):337. doi: 10.3892/etm.2024.12626. eCollection 2024 Sep.
5
Updated Considerations for the Immunopharmacological Aspects of the "Talented mRNA Vaccines".“卓越信使核糖核酸疫苗”免疫药理学方面的最新考量
Vaccines (Basel). 2023 Sep 12;11(9):1481. doi: 10.3390/vaccines11091481.
6
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
7
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.接种 BNT162b2 mRNA COVID-19 疫苗后出现新发性巨核细胞减少性血小板减少症，并有进展为再生障碍性贫血的可能。
Int J Hematol. 2023 Oct;118(4):477-482. doi: 10.1007/s12185-023-03618-7. Epub 2023 May 23.
8
Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study.新冠疫苗接种后自身免疫性疾病的出现：一项单中心研究
Infect Drug Resist. 2023 Mar 4;16:1263-1278. doi: 10.2147/IDR.S394602. eCollection 2023.
9
People having hematological disorders and hypercoagulability state need extra precautions because of the increased risk of thrombosis after COVID-19 vaccination.患有血液系统疾病和高凝状态的人由于在接种新冠疫苗后发生血栓形成的风险增加，需要格外注意。
Front Med (Lausanne). 2023 Feb 14;9:1082611. doi: 10.3389/fmed.2022.1082611. eCollection 2022.
10
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?新冠疫苗会引发过早的非传染性疾病吗：我们正走向何方？
Vaccines (Basel). 2023 Jan 17;11(2):208. doi: 10.3390/vaccines11020208.
本文引用的文献
1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
2
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
3
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
4
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
5
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.儿童和成人免疫性血小板减少性紫癜的发病率：已发表报告的批判性回顾。
Am J Hematol. 2010 Mar;85(3):174-80. doi: 10.1002/ajh.21616.
6
Drug-induced thrombocytopenia: pathogenesis, evaluation, and management.药物诱导的血小板减少症：发病机制、评估和管理。
Hematology Am Soc Hematol Educ Program. 2009:153-8. doi: 10.1182/asheducation-2009.1.153.
Zotero 插件